If you're looking for the Minnesota Organization on Fetal Alcohol Syndrome (MOFAS) you have come to the right place. We have some exciting news about our organization. We have a new name! MOFAS has officially been renamed Proof Alliance. Our mission remains the same: to prevent prenatal alcohol exposure and to improve the quality of life for people living with fetal alcohol spectrum disorders (FASD).
We now have the proof that prenatal alcohol exposure is a leading cause of brain injury in children. We have the proof that FASD is 100% preventable and people living with an FASD can reach 100% of their potential.
We seek to build powerful alliances with people with an FASD, their families, legislators, experts in the field, new partners, and community members to bring awareness, research, and services to this field.
Proof Alliance is rebranding, expanding, and we're moving! We have a new logo, website, and prevention campaign to help change the norms around drinking during pregnancy. And in May 2019 we will be moving to a stand-alone building. Proof Alliance commits to the people of Minnesota and we will continue to develop transformative programs to help Minnesotans impacted by FASD.
October 15, 2015
The results of the 5-year trial of choline as a treatment for FASD has been published in the October issue of The American Journal of Clinical Nutrition. This ground breaking research was led by Dr. Jeffrey Wozniak with the University of Minnesota, and included participation from several families connected to MOFAS. The primary goal of the study was to determine whether choline supplements would improve cognitive functioning in children with an FASD. The pilot study suggests that choline is promising in improving memory function and additional evaluation is warranted. This is significant and hopeful news for the FASD community. Read the study for more information.